{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:32:24Z","timestamp":1786116744305,"version":"build-2736575974"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T00:00:00Z","timestamp":1771977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T00:00:00Z","timestamp":1771977600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s10620-026-09725-9","type":"journal-article","created":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T05:15:16Z","timestamp":1771996516000},"page":"3095-3106","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Epidemiology and Treatment of Inflammatory Bowel Disease in Pregnancy: Results from a Retrospective, Observational Study"],"prefix":"10.1007","volume":"71","author":[{"given":"Uma","family":"Mahadevan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce E.","family":"Sands","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Ha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doris","family":"Yimgang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carrie","family":"Huisingh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Law","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecile T. J.","family":"Holweg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lani","family":"Wegrzyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marla","family":"Dubinsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,25]]},"reference":[{"key":"9725_CR1","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/s41575-020-0354-0","volume":"17","author":"WA Goodman","year":"2020","unstructured":"Goodman WA, Erkkila IP, Pizarro TT. Sex matters: impact on pathogenesis, presentation and treatment of inflammatory bowel disease. Nat Rev Gastroenterol Hepatol 2020;17:740\u2013754. https:\/\/doi.org\/10.1038\/s41575-020-0354-0.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"9725_CR2","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1053\/j.gastro.2018.06.043","volume":"155","author":"SC Shah","year":"2018","unstructured":"Shah SC, Khalili H, Gower-Rousseau C et al. Sex-based differences in incidence of inflammatory bowel diseases-pooled analysis of population-based studies from Western countries. Gastroenterology 2018;155:1079\u201389.e3. https:\/\/doi.org\/10.1053\/j.gastro.2018.06.043.","journal-title":"Gastroenterology"},{"key":"9725_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ecco-jcc\/jjac115","volume":"17","author":"J Torres","year":"2023","unstructured":"Torres J, Chaparro M, Julsgaard M et al. European Crohn\u2019s and colitis guidelines on sexuality, fertility, pregnancy, and lactation. J Crohns Colitis 2023;17:1\u201327. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjac115.","journal-title":"J Crohns Colitis"},{"key":"9725_CR4","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.ajog.2019.02.027","volume":"220","author":"U Mahadevan","year":"2019","unstructured":"Mahadevan U, Robinson C, Bernasko N et al. Inflammatory bowel disease in pregnancy clinical care pathway: a report from the American Gastroenterological Association IBD Parenthood Project Working Group. Am J Obstet Gynecol 2019;220:308\u2013323. https:\/\/doi.org\/10.1016\/j.ajog.2019.02.027.","journal-title":"Am J Obstet Gynecol"},{"key":"9725_CR5","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1007\/s40264-024-01454-0","volume":"47","author":"U Mahadevan","year":"2024","unstructured":"Mahadevan U, Levy G, Gensler L et al. Pregnancy outcomes in patients treated with upadacitinib: analysis of data from clinical trials and postmarketing reports. Drug Saf 2024;47:1039\u20131049. https:\/\/doi.org\/10.1007\/s40264-024-01454-0.","journal-title":"Drug Saf"},{"key":"9725_CR6","unstructured":"Merative. Marketscan research databases. 2025. https:\/\/www.merative.com\/documents\/use-real-world-healthcare-data-to-analyze-utilization-patterns-and-costs. Accessed January 7, 2025."},{"key":"9725_CR7","doi-asserted-by":"publisher","first-page":"567","DOI":"10.2337\/cd23-0008","volume":"41","author":"LA Abushamat","year":"2023","unstructured":"Abushamat LA, Sayres L, Jeffers R, Nielsen C, Barbour LA, Zaman A. Unmasking barriers in the delivery of preconception counseling and contraception provision for patients with type 1 or type 2 diabetes. Clin Diabetes 2023;41:567\u2013572. https:\/\/doi.org\/10.2337\/cd23-0008.","journal-title":"Clin Diabetes"},{"key":"9725_CR8","doi-asserted-by":"publisher","first-page":"e0002592","DOI":"10.1371\/journal.pgph.0002592","volume":"3","author":"DB Stulberg","year":"2023","unstructured":"Stulberg DB, Schumm LP, Schueler K, Giurcanu M, Peek ME. Preconception care utilization: self-report versus claims-based measures among women with Medicaid. PLOS Glob Public Health 2023;3:e0002592. https:\/\/doi.org\/10.1371\/journal.pgph.0002592.","journal-title":"PLOS Glob Public Health"},{"key":"9725_CR9","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1093\/jcag\/gwac003","volume":"5","author":"P Tandon","year":"2022","unstructured":"Tandon P, Tennakoon A, Huang V, Bernstein CN, Goetgebuer R, Targownik L. Pregnancy and live birth rates over time in women with inflammatory bowel disease: a population-based cohort study. J Can Assoc Gastroenterol 2022;5:184\u2013191. https:\/\/doi.org\/10.1093\/jcag\/gwac003.","journal-title":"J Can Assoc Gastroenterol"},{"key":"9725_CR10","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1111\/apt.15654","volume":"51","author":"HH Lee","year":"2020","unstructured":"Lee HH, Bae JM, Lee BI et al. Pregnancy outcomes in women with inflammatory bowel disease: a 10-year nationwide population-based cohort study. Aliment Pharmacol Ther 2020;51:861\u2013869. https:\/\/doi.org\/10.1111\/apt.15654.","journal-title":"Aliment Pharmacol Ther"},{"key":"9725_CR11","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1111\/apt.13354","volume":"42","author":"L Ban","year":"2015","unstructured":"Ban L, Tata LJ, Humes DJ, Fiaschi L, Card T. Decreased fertility rates in 9639 women diagnosed with inflammatory bowel disease: a United Kingdom population-based cohort study. Aliment Pharmacol Ther 2015;42:855\u2013866. https:\/\/doi.org\/10.1111\/apt.13354.","journal-title":"Aliment Pharmacol Ther"},{"key":"9725_CR12","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1093\/ecco-jcc\/jjw078","volume":"10","author":"CP Selinger","year":"2016","unstructured":"Selinger CP, Ghorayeb J, Madill A. What factors might drive voluntary childlessness (VC) in women with IBD? Does IBD-specific pregnancy-related knowledge matter? J Crohns Colitis 2016;10:1151\u20131158. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjw078.","journal-title":"J Crohns Colitis"},{"key":"9725_CR13","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.cgh.2006.10.018","volume":"5","author":"A Timmer","year":"2007","unstructured":"Timmer A, Bauer A, Dignass A, Rogler G. Sexual function in persons with inflammatory bowel disease: a survey with matched controls. Clin Gastroenterol Hepatol 2007;5:87\u201394. https:\/\/doi.org\/10.1016\/j.cgh.2006.10.018.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"9725_CR14","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1097\/meg.0000000000001037","volume":"30","author":"J Walldorf","year":"2018","unstructured":"Walldorf J, Brunne S, Gittinger FS, Michl P. Family planning in inflammatory bowel disease: childlessness and disease-related concerns among female patients. Eur J Gastroenterol Hepatol 2018;30:310\u2013315. https:\/\/doi.org\/10.1097\/meg.0000000000001037.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"9725_CR15","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1111\/apt.12478","volume":"38","author":"N Tavernier","year":"2013","unstructured":"Tavernier N, Fumery M, Peyrin-Biroulet L, Colombel JF, Gower-Rousseau C. Systematic review: fertility in non-surgically treated inflammatory bowel disease. Aliment Pharmacol Ther 2013;38:847\u2013853. https:\/\/doi.org\/10.1111\/apt.12478.","journal-title":"Aliment Pharmacol Ther"},{"key":"9725_CR16","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1093\/ecco-jcc\/jju006","volume":"9","author":"CJ van der Woude","year":"2015","unstructured":"van der Woude CJ, Ardizzone S, Bengtson MB et al. The second European evidenced-based consensus on reproduction and pregnancy in inflammatory bowel disease. J Crohns Colitis 2015;9:107\u2013124. https:\/\/doi.org\/10.1093\/ecco-jcc\/jju006.","journal-title":"J Crohns Colitis"},{"key":"9725_CR17","doi-asserted-by":"publisher","first-page":"e2510504","DOI":"10.1001\/jamanetworkopen.2025.10504","volume":"8","author":"CLY Ewig","year":"2025","unstructured":"Ewig CLY, Wang Y, Smolinski NE, Thai TN, Rasmussen SA, Winterstein AG. Use of biologics during pregnancy among patients with autoimmune conditions. JAMA Netw Open 2025;8:e2510504. https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.10504.","journal-title":"JAMA Netw Open"},{"key":"9725_CR18","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.rdc.2017.04.013","volume":"43","author":"G Bandoli","year":"2017","unstructured":"Bandoli G, Palmsten K, Forbess Smith CJ, Chambers CD. A review of systemic corticosteroid use in pregnancy and the risk of select pregnancy and birth outcomes. Rheum Dis Clin North Am 2017;43:489\u2013502. https:\/\/doi.org\/10.1016\/j.rdc.2017.04.013.","journal-title":"Rheum Dis Clin North Am"},{"key":"9725_CR19","doi-asserted-by":"publisher","first-page":"579","DOI":"10.20524\/aog.2020.0536","volume":"33","author":"MF Ali","year":"2020","unstructured":"Ali MF, He H, Friedel D. Inflammatory bowel disease and pregnancy: fertility, complications and treatment. Ann Gastroenterol 2020;33:579\u201390. https:\/\/doi.org\/10.20524\/aog.2020.0536.","journal-title":"Ann Gastroenterol"},{"key":"9725_CR20","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1111\/apt.15596","volume":"51","author":"S Lee","year":"2020","unstructured":"Lee S, Seow CH, Adhikari K, Metcalfe A. Pregnant women with IBD are more likely to be adherent to biologic therapies than other medications. Aliment Pharmacol Ther 2020;51:544\u2013552. https:\/\/doi.org\/10.1111\/apt.15596.","journal-title":"Aliment Pharmacol Ther"},{"key":"9725_CR21","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.ijnurstu.2018.06.009","volume":"87","author":"J Goossens","year":"2018","unstructured":"Goossens J, De Roose M, Van Hecke A, Goemaes R, Verhaeghe S, Beeckman D. Barriers and facilitators to the provision of preconception care by healthcare providers: a systematic review. Int J Nurs Stud 2018;87:113\u2013130. https:\/\/doi.org\/10.1016\/j.ijnurstu.2018.06.009.","journal-title":"Int J Nurs Stud"},{"key":"9725_CR22","first-page":"1","volume":"70","author":"BE Hamilton","year":"2021","unstructured":"Hamilton BE. Total fertility rates, by maternal educational attainment and race and hispanic origin: United States, 2019. Natl Vital Stat Rep 2021;70:1\u20139.","journal-title":"Natl Vital Stat Rep"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-026-09725-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-026-09725-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-026-09725-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T11:54:16Z","timestamp":1786017256000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-026-09725-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,25]]},"references-count":22,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["9725"],"URL":"https:\/\/doi.org\/10.1007\/s10620-026-09725-9","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,25]]},"assertion":[{"value":"13 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"UM has received consultant fees from AbbVie, BMS, BI, Celltrion, Enveda, Gilead, Janssen, Lilly, Pfizer, Protagonist, Roivant, and Takeda; served on the data and safety monitoring board for Merck and Prometheus Biosciences; served on the scientific advisory board for Rani Therapeutics; and received research funding from the Helmsley Charitable Trust. BES reports consulting fees from AbbVie, Adiso, Agomab, Alimentiv, Amgen, AnaptysBio, Arena, Artugen, AstraZeneca, BI, Biolojic Design, Biora, Boston, Calibr, Celgene, Celltrion, ClostraBio, Equillium, Enthera, Envied, Evommune, Ferring, Fresenius Kabi, Fiat, Galapagos, Genentech (Roche), Gilead, Gossamer Bio, GSK, Imhotex, Index, Innovation, Inotrem, Kaleido, Kallyope, Merck, Microbiotica, Mitsubishi Tanabe, Mobius Care, Morphic, MRM Health, Nexus, Nimbus Discovery, Odyssey, Palisade Bio, Progenity, Prometheus Biosciences, Prometheus Laboratories, Protagonist, Q32 Bio, Rasayana, Recludix, Reistone, Sanofi, Sorriso, Spyre, Sun, Surrozen, Target RWE, Teva, TLL, Tr1X, Union, and Ventyx; consulting and speaking fees from Abivax; consulting and speaking fees and other support from Lilly; research grants, consulting and speaking fees, and other support from BMS, Janssen, Pfizer, and Takeda; research grants and consulting fees from Theravance; and stock or stock options from Ventyx. CH has provided consulting services or served on advisory boards for AbbVie, Bausch Health, Genentech, J&J, Lilly, Pfizer, Sanofi, and Takeda. She has received educational programming support from AbbVie, J&J, Pfizer, and Takeda. DY, CH, LL, CTJH, and LW are full-time employees of AbbVie Inc. and may hold AbbVie stock and\/or options. EY was a full-time employee of AbbVie. MD has served as a consultant for AbbVie, Abivax, Arena, AstraZeneca, BMS, Celgene, Genentech, Gilead, Janssen, Lilly, Pfizer, Prometheus Laboratories, and Takeda.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"As this study was noninterventional and used deidentified patient data, approval from an institutional review board was not required. All authors had access to the study data and reviewed and approved the final manuscript.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"As this study was noninterventional and used deidentified patient data, informed consent was not required.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Consent for publication was not required.","order":4,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}]}}